Skip to main content
Toggle navigation
Login
Search
Home
Full Schedule
Home
Full Schedule
All Days
Tue, Jul 15
Wed, Jul 16
Thu, Jul 17
Fri, Jul 18
Full Schedule
Type here to filter the list
Wednesday, July 16, 2025
8:15 AM - 8:30 AM
HST
RP2D Determination of Bleximenib in Combination With VEN+AZA: Phase 1B Study in ND & R/R AML With KMT2A/NPM1 Alterations
8:15 AM - 8:30 AM
HST
RP2D Determination of Bleximenib in Combination With VEN+AZA: Phase 1B Study in ND & R/R AML With KMT2A/NPM1 Alterations
Presenter:
Andrew Wei, MBBS, PhD
– Peter MacCallum Cancer Centre at Royal Melbourne Hospital
8:15 AM - 11:05 AM
HST
Acute Lymphoblastic Leukemia (ALL)
8:15 AM - 11:05 AM
HST
Moderator
Moderator:
Ryan D. Cassaday, MD (he/him/his)
– University of Washington School of Medicine
Moderator:
Nitin Jain, MD
– The University of Texas MD Anderson Cancer Center
8:30 AM - 8:45 AM
HST
Efficacy/Safety of the BTK Degrader NX-5948 in Patients With Chronic Lymphocytic Leukemia: An Ongoing Phase 1A/B Study
8:30 AM - 8:45 AM
HST
Efficacy/Safety of the BTK Degrader NX-5948 in Patients With Chronic Lymphocytic Leukemia: An Ongoing Phase 1A/B Study
Presenter:
William G. Wierda, MD, PhD
– The University of Texas MD Anderson Cancer Center
8:45 AM - 9:00 AM
HST
Acute Lymphoblastic Leukemia (ALL)
8:45 AM - 9:00 AM
HST
How Do I Treat Adults with Newly Diagnosed Ph-Negative B-ALL?
Presenter:
Marlise R. Luskin, MD, MSCE
– Dana-Farber Cancer Institute
9:00 AM - 9:15 AM
HST
Acute Lymphoblastic Leukemia (ALL)
9:00 AM - 9:15 AM
HST
How Do I Treat Central Nervous System Disease in ALL?
Presenter:
Ryan D. Cassaday, MD (he/him/his)
– University of Washington School of Medicine
9:15 AM - 9:30 AM
HST
Acute Lymphoblastic Leukemia (ALL)
9:15 AM - 9:30 AM
HST
How Do I Use CAR-T in Adult ALL?
Presenter:
Lori Muffly, MD, MS
– Stanford University
9:30 AM - 9:45 AM
HST
Acute Lymphoblastic Leukemia (ALL)
9:30 AM - 9:45 AM
HST
How Do I Use CAR-T in Pediatric ALL?
Presenter:
Stephan A. Grupp, MD, PhD
– Children's Hospital of Philadelphia
10:20 AM - 10:35 AM
HST
Acute Lymphoblastic Leukemia (ALL) - Chemotherapy Options for Upfront Management of ALL
10:20 AM - 10:35 AM
HST
Use of Asparaginase in ALL – When and How
Presenter:
Wendy Stock, MD
– University of Chicago
10:35 AM - 10:50 AM
HST
Acute Lymphoblastic Leukemia (ALL) - Chemotherapy Options for Upfront Management of ALL
10:35 AM - 10:50 AM
HST
Chemotherapy-Free Regimens for Ph-Positive ALL
Presenter:
Marlise R. Luskin, MD, MSCE
– Dana-Farber Cancer Institute
10:50 AM - 11:05 AM
HST
Acute Lymphoblastic Leukemia (ALL) - Chemotherapy Options for Upfront Management of ALL
10:50 AM - 11:05 AM
HST
BCL2 and BCL-XL Inhibition in ALL – Ready for Primetime?
Presenter:
Nitin Jain, MD
– The University of Texas MD Anderson Cancer Center
11:20 AM - 11:35 AM
HST
Myeloproliferative Neoplasms (MPN)
11:20 AM - 11:35 AM
HST
How Many Janus Kinase (JAK) Inhibitors Do We Need in Myelofibrosis (MF)?
Presenter:
Ruben A. Mesa, MD, FACP
– Atrium Health Wake Forest Baptist
11:35 AM - 11:50 AM
HST
Myeloproliferative Neoplasms (MPN)
11:35 AM - 11:50 AM
HST
Can We Modify the Disease in MF? How?
Presenter:
Naveen Pemmaraju, MD
– The University of Texas MD Anderson Cancer Center
11:50 AM - 12:05 PM
HST
Myeloproliferative Neoplasms (MPN)
11:50 AM - 12:05 PM
HST
What’s New in Polycythemia Vera?
Presenter:
Olatoyosi Odenike, MD
– University of Chicago
12:05 PM - 12:20 PM
HST
Myeloproliferative Neoplasms (MPN)
12:05 PM - 12:20 PM
HST
What’s New in Essential Thrombocythaemia?
Presenter:
Laura C. Michaelis, MD
– Medical College of Wisconsin
3:00 PM - 4:00 PM
HST
Meet the Experts
3:00 PM - 4:00 PM
HST
Meet the Experts - Acute Myeloid Leukemia (AML) / Myelodysplastic Syndrome (MDS)
Moderator:
Vijaya Raj Bhatt, MBBS, MS
– University of Nebraska Medical Center
Panelist:
Geoffrey L. Uy, MD
– Washington University School of Medicine
Panelist:
Eunice S. Wang, MD
– Roswell Park Comprehensive Cancer Center
Panelist:
Olatoyosi Odenike, MD
– University of Chicago
4:00 PM - 5:00 PM
HST
Meet the Experts
4:00 PM - 5:00 PM
HST
Meet the Experts - Chronic Lymphocytic Leukemia (CLL)
Moderator:
Nitin Jain, MD
– The University of Texas MD Anderson Cancer Center
Panelist:
Matthew A. Lunning, DO, FACP (he/him/his)
– University of Nebraska Medical Center
Panelist:
Susan O'Brien, MD (she/her/hers)
– University of California Irvine
Panelist:
Julie M. Vose, MD, MBA (she/her/hers)
– University of Nebraska Medical Center